Table 2.

Clinical Characteristics of Study Sample

	N = 162
IBD Diagnosis
Crohn’s Disease	58.8% (96)
Ulcerative Colitis (includes post-colectomy)	39.0% (63)
Indeterminate Colitis	1.7% (3)
Primary IBD Treatment Provider
Internist/Primary Care Physician	9.3% (15)
General Gastroenterologist	37.9% (61)
IBD Specialist	48.4% (79)
Nurse Practitioner/Advanced Practice Nurse	2.5% (4)
Other	1.9% (3)
Current Medication
Antibiotics	2.2% (4)
Aminosalicylates	23.5% (43)
Steroids	13.1% (24)
Immunomodulators	19.1% (35)
Biologic Therapies	43.2% (79)
Other Prescribed Medications	15.8% (29)
Over the Counter Medication, Supplements, Probiotics	57.1% (92)
Age Symptom Onset (years)	24.60 ± 44.22
Age of Diagnosis (years)	26.58 ± 12.40
Harvey Bradshaw Index Score	8.89 ± 4.66
SIBQ Score	43.23 ± 12.58
Number of Outpatient Visits for IBD (past year)	4.52 ± 8.68
Good or Excellent Relationship with IBD Provider	80.6% (129)
Good or Excellent Communication with IBD Provider	74.5% (120)